• NPPA'S HELPLINE NO. 1800111255

NPPA has fixed/ revised prices of 16 formulations packs on 10th April, 2002. These include formulations based on bulk drug Pyrantel Pamoate an Insulin.

Dated : 11th April, 2002

The National Pharmaceutical Pricing Authority has revised/fixed the prices of 16 formulation packs on April 10, 2002. In the case of 12 packs, prices have been increased ranging from 5.13% to 19.63%. Of the 16 formulation packs, ceiling prices have been fixed in respect of 3 packs and for rest 13 packs non-ceiling price have been fixed. The formulations for which prices have been fixed/ revised include formulations based on bulk drugs Pyrantel Pamoate, Insulin and Ephedrine. These formulations are used in various treatments/ diseases like anti-helminthics, diabetes and ashtamaic disorders etc.

For details please click the following:

  1. Copy of Press Release/Explanatory Note
  2. Copy of Statement (for details of existing and revised prices).
  3. Ceiling Price
S.No S.O.No Date Formulations based on
a. 400(E) 10-4-2002 Pyrantel Pamoate
  1. Non Ceiling Prices
Sl. No. Company Name Product Name
(i) Eli Lilly and Company (I) Pvt. Ltd. Monocomponent Insulin
(ii) M.J. Pharmaceuticals Ltd. Huminsulin NPH/ Human Insulin
(iii) Nicholas Piramal (I) Ltd. Asmapax Depot
(iv) Novo-Nordisk (I) Pvt. Ltd. Actrapid HM Vials/ Monotard HM/
Mixtard HM/ Actrapid HM Penfill/
Mixtard HM Penfill/ Insulatard HM Penfill

(Dr. P.V. Appaji)

Last Page Updated: 31-05-2019